159 related articles for article (PubMed ID: 30671402)
1. Plasma Adropin as a Potential Marker Predicting Obesity and Obesity-associated Cancer in Korean Patients With Type 2 Diabetes Mellitus.
Choi HN; Yim JE
J Cancer Prev; 2018 Dec; 23(4):191-196. PubMed ID: 30671402
[TBL] [Abstract][Full Text] [Related]
2. Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease.
Li N; Xie G; Zhou B; Qu A; Meng H; Liu J; Wang G
Front Physiol; 2021; 12():696163. PubMed ID: 34366886
[No Abstract] [Full Text] [Related]
3. Novel associations of serum adropin and lipopolysaccharide-binding protein versus lipid profiles in childhood obesity.
Yuan X; Chen R; Ouyang Q; Lin X; Ai Z; Zhang Y; Yang X
J Pediatr Endocrinol Metab; 2020 Feb; 33(2):265-270. PubMed ID: 31953997
[TBL] [Abstract][Full Text] [Related]
4. Association of Serum Adropin Concentrations with Diabetic Nephropathy.
Hu W; Chen L
Mediators Inflamm; 2016; 2016():6038261. PubMed ID: 27546995
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal changes in serum adropin levels and liver fat content during liraglutide treatment in newly diagnosed patients with type 2 diabetes mellitus and metabolic dysfunction-associated fatty liver disease.
Zhang L; Wu X; Li X; Chang X; Ding X; Wang Q; Jiang T; Wang G; Liu J
Acta Diabetol; 2023 Jul; 60(7):971-979. PubMed ID: 37079136
[TBL] [Abstract][Full Text] [Related]
6. The association between serum adropin and carotid atherosclerosis in patients with type 2 diabetes mellitus: a cross‑sectional study.
Wei W; Liu H; Qiu X; Zhang J; Huang J; Chen H; Qiu S; Lin R; Li S; Tu M
Diabetol Metab Syndr; 2022 Feb; 14(1):27. PubMed ID: 35135590
[TBL] [Abstract][Full Text] [Related]
7. Elevated Serum TNF-
Alzamil H
J Obes; 2020; 2020():5076858. PubMed ID: 32089876
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Syndrome Patients Have Lower Levels of Adropin When Compared With Healthy Overweight/Obese and Lean Subjects.
Yosaee S; Khodadost M; Esteghamati A; Speakman JR; Shidfar F; Nazari MN; Bitarafan V; Djafarian K
Am J Mens Health; 2017 Mar; 11(2):426-434. PubMed ID: 27550773
[TBL] [Abstract][Full Text] [Related]
9. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.
Li B; Tian X; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
Int Urol Nephrol; 2020 Nov; 52(11):2145-2152. PubMed ID: 32661627
[TBL] [Abstract][Full Text] [Related]
10. Adropin deficiency worsens HFD-induced metabolic defects.
Chen S; Zeng K; Liu QC; Guo Z; Zhang S; Chen XR; Lin JH; Wen JP; Zhao CF; Lin XH; Gao F
Cell Death Dis; 2017 Aug; 8(8):e3008. PubMed ID: 28837146
[TBL] [Abstract][Full Text] [Related]
11. Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus.
Elizondo-Montemayor L; Gonzalez-Gil AM; Tamez-Rivera O; Toledo-Salinas C; Peschard-Franco M; Rodríguez-Gutiérrez NA; Silva-Platas C; Garcia-Rivas G
Mediators Inflamm; 2019; 2019():6737318. PubMed ID: 31015797
[TBL] [Abstract][Full Text] [Related]
12. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
13. Adropin and Inflammation Biomarker Levels in Male Patients With Obstructive Sleep Apnea: A Link With Glucose Metabolism and Sleep Parameters.
Bozic J; Borovac JA; Galic T; Kurir TT; Supe-Domic D; Dogas Z
J Clin Sleep Med; 2018 Jul; 14(7):1109-1118. PubMed ID: 29991422
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents].
Yang SP; Gong CX; Cao BY; Yan C
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):933-6. PubMed ID: 17254464
[TBL] [Abstract][Full Text] [Related]
15. Relationship between plasma adropin levels and body composition and lipid characteristics amongst young adolescents in Taiwan.
Chang JB; Chu NF; Lin FH; Hsu JT; Chen PY
Obes Res Clin Pract; 2018; 12(Suppl 2):101-107. PubMed ID: 28363705
[TBL] [Abstract][Full Text] [Related]
16. Assessment of serum and salivary adiponectin levels in newly diagnosed Type II diabetes mellitus patients.
Kalyani RS; Raghunath V
J Oral Maxillofac Pathol; 2020; 24(2):245-250. PubMed ID: 33456232
[TBL] [Abstract][Full Text] [Related]
17. Obesity, Leukocytes, and High-Sensitivity C-Reactive Protein Biomarkers Associated with Type 2 Diabetes Mellitus in South Korean Adults.
Park SH; Lee H
Iran J Public Health; 2022 Aug; 51(8):1827-1835. PubMed ID: 36249117
[TBL] [Abstract][Full Text] [Related]
18. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans.
Butler AA; Tam CS; Stanhope KL; Wolfe BM; Ali MR; O'Keeffe M; St-Onge MP; Ravussin E; Havel PJ
J Clin Endocrinol Metab; 2012 Oct; 97(10):3783-91. PubMed ID: 22872690
[TBL] [Abstract][Full Text] [Related]
19. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
20. Adropin and apelin-12 efficiently predict metabolic syndrome in obese children.
Yin C; Zhang H; Zhang M; Xiao Y
Pediatr Diabetes; 2020 Nov; 21(7):1132-1139. PubMed ID: 32749012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
